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PEGylation is frequently used to improve the efficacy of protein and peptide drugs. Recently, we investigated its effects on the action
mechanism of the cyclic β-sheet antimicrobial peptide tachyplesin I isolated from Tachypleus tridentatus [Y. Imura, M. Nishida, Y. Ogawa, Y.
Takakura, K. Matsuzaki, Action Mechanism of Tachyplesin I and Effects of PEGylation, Biochim. Biophys. Acta 1768 (2007) 1160–1169].
PEGylation did not change the basic mechanism behind the membrane-permeabilizing effect of the peptide on liposomes, however, it decreased
the antimicrobial activity and cytotoxicity. To obtain further information on the effects of PEGylation on the activities of antimicrobial peptides,
we designed another structurally different PEGylated antimicrobial peptide (PEG-F5W, E19Q-magainin 2-amide) based on the α-helical peptide
magainin 2 isolated from the African clawed frog Xenopus laevis. The PEGylated peptide induced the leakage of calcein from egg yolk L-α-
phosphatidylglycerol/egg yolk L-α-phosphatidylcholine large unilamellar vesicles, however, the activity was weaker than that of the control
peptides. The PEGylated peptide induced lipid flip-flop coupled to the leakage and was translocated into the inner leaflet of the bilayer, indicating
that PEGylation did not alter the basic mechanism of membrane permeabilization of the parent peptide. The cytotoxicity of the non-PEGylated
peptides was nullified by PEGylation. At the same time, the antimicrobial activity was weakened only by 4 fold. The effects of PEGylation on the
activity of magainin were compared with those for tachyplesin.
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More than 880 antimicrobial peptides have been isolated
from plants, insects and animals including humans or predicted
from gene sequences [1,2]. These peptides are considered to playAbbreviations: Ac-E19Q-MGa, Ac-F5W, E19Q-magainin 2-amide;
AMEM, Alpha modification of Eagle's medium; C6-NBD-PC, 1-palmitoyl-2-
[6-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]caproyl]-L-α-phosphatidylcho-
line; CD, circular dichroism; CFU, colony forming unit; CHO, Chinese
Hamster Ovary; FBS, fetal bovine serum; Fmoc, 9-fluorenylmethoxycarbonyl;
HPLC, high-performance liquid chromatography; L/P, lipid-to-peptide molar
ratio; LUVs, large unilamellar vesicles; MG, F5W-magainin 2; MIC, minimal
inhibitory concentration; MLVs, multilamellar vesicles; NAPB, 10 mM sodium
phosphate/100 mMNaCl, pH 7.4 buffer; ONPG, o-nitrophenyl-β-D-galactoside;
PC, egg yolk L-α-phosphatidylcholine; PEG, polyethyleneglycol; PEG-E19Q-
MGa, PEG-F5W, E19Q-magainin 2-amide; PG, L-α-phosphatidyl-DL-glycerol
enzymatically converted from PC; SUVs, small unilamellar vesicles; TSB,
tryptic soy broth; WST-1, 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfo-
phenyl)-2H-tetrazolium, monosodium salt
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Antimicrobial peptides are promising candidates for novel
therapeutic agents because they are effective against antibiotic-
resistant bacteria. However, their application is limited to topical
use [1,3] because of disadvantages such as plausible antigeni-
city, a short circulating half-life due to protease digestion, and a
rapid clearance from kidney [4,5], and low therapeutic indices in
vivo [1,6]. Several attempts have been made to improve the
therapeutic indices of antimicrobial peptides, for example, the
entrapment of indolicidin in liposomes [7].
Attaching a polyethyleneglycol (PEG) moiety to peptide and
protein drugs (PEGylation) is frequently used to improve
efficacy in vivo [4]. However, regarding antimicrobial peptides,
there had been only one short report about the PEGylation of
nisin [8] until our recent paper.We have reported that theβ-sheet
peptide tachyplesin I forms a toroidal pore and that PEGylation
does not alter the basic mechanism of membrane permeabiliza-
tion of the parent peptide. Despite similar activities against
model membranes, the cytotoxicity of tachyplesin I was greatly
reduced by PEGylation, although the antimicrobial activity was
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peptidoglycan layers play an inhibitory role in the permeation of
the PEG moiety into cell membranes [9].
Although PEGylation decreased biological activities of
tachyplesin I, a question still remains: whether the results are
general to antimicrobial peptides or are specific for the peptide.
To obtain further information about the effects of PEGylation, we
designed another structurally different PEGylated antimicrobial
peptide based on magainin 2. Magainin 2 was isolated from the
African clawed frogXenopus laevis (Fig. 1) [10] and is one of the
most studied α-helical antimicrobial peptides [11]. The peptide
induces membrane permeabilization and lipid flip-flop via a
toroidal pore consisting of peptide and lipid molecules [12,13].
In this study, PEG (M.W.=5000) was attached to the
N-terminus of F5W, E19Q-magainin 2-amide (PEG-E19Q-
MGa). The E19Q substitution and C-terminal amidation are
expected to enhance antimicrobial activity by increasing positive
charges [14]. Introduction of a Trp residue enables fluorome-
trical monitoring of peptide–membrane interaction. Ac-F5W,
E19Q-magainin 2-amide (Ac-E19Q-MGa) was used as a control
for PEG-E19Q-MGa. F5W-magainin 2 (MG), an equipotent
analogue of magainin 2 [15], was also used as another control.
We compared PEG-E19Q-MGa, Ac-E19Q-MGa, and MG
(Fig. 1) in terms of conformation, membrane binding,
antimicrobial activity, cytotoxicity against mammalian cells,
and membrane-permeabilizing activity against liposomes and
Escherichia coli ML-35. We also compared and discussed the
effects of PEGylation on the activities of α-helical magainin 2
and β-sheet tachyplesin I.
2. Materials and methods
2.1. Peptides
PEG-E19Q-MGa and Ac-E19Q-MGa were custom synthesized by Peptide
Institute (Minou, Japan) and Toray Research Center (Tokyo, Japan),
respectively. MG was synthesized by a standard Fmoc-based solid phase
method as described elsewhere [15]. The concentrations of all peptides were
determined on the basis of tryptophan UV absorption.
2.2. Liposomes
Egg yolk L-α-phosphatidylcholine (PC) and L-α-phosphatidyl-DL-glycerol
enzymatically converted from PC (PG) were obtained from Sigma (St. Louis,Fig. 1. Amino acid sequences of the peptides used in this study.MO). Calcein was supplied by Dojindo (Kumamoto, Japan). The fluorescent
lipid, 1-palmitoyl-2-[6-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]caproyl]-L-
α-phosphatidylcholine (C6-NBD-PC) was purchased from Molecular Probes
(Eugene, OR). All other chemicals were of special grade and were obtained from
Wako (Osaka, Japan).
The lipid composition of bacterial inner membranes significantly differs
strain by strain. For example, the inner membrane of Staphylococcus
epidermidis is mainly composed of PG, and Pseudomonas carboxydovorans
contains PC. We have been using PG/PC (1/1) system as a model for bacterial
inner membranes. A mixture of phosphatidylethanolamine and PG is often used
to mimic the inner membrane of E. coli. Incorporation of phosphatidylethano-
lamine is expected to decrease membrane-permeabilizing activity of MG as
shown in our previous study [16].
Large unilamellar vesicles (LUVs) were prepared and characterized, as
previously described elsewhere [15]. Briefly, a lipid film, after being dried under
vacuum overnight, was hydrated with a Tris buffer (10 mM Tris/l50 mM NaCl/
1 mM EDTA, pH 7.4) or a 70 mM calcein solution (pH was adjusted to 7.4 with
1 N NaOH) and vortexed. The suspension was freeze–thawed for 10 cycles to
produce multilamellar vesicles (MLVs).
For CD measurements, small unilamellar vesicles (SUVs) were prepared by
sonication of MLVs in ice/water under a nitrogen atmosphere.
MLVs used in translocation experiments were freeze–thawed only once to
keep the lamellarity larger than 1. MLVs were then successively extruded
through polycarbonate filters (a 100 nm pore size filter×31 times) to obtain
LUVs. Dye-entrapped vesicles were separated from free calcein on a Bio-Gel
A-1.5 m column. The lipid concentration was determined by phosphorus
analysis [17].
2.3. CD spectra
CD spectra were measured on a Jasco J-820 at 30 °C using a 1-mm path-
length quartz cell to minimize the absorbance due to buffer components. Eight
scans were averaged for each sample. The averaged blank spectra (the vesicle
suspension) were subtracted. Spectra of the peptides in the membrane-bound
form were recorded by use of PG/PC (1/1) SUVs. The peptide and the lipid
concentrations were 25 μM and 1.0 mM or 2.0 mM, respectively. The absence of
any optical artifacts was confirmed elsewhere [18].
2.4. Calcein leakage
The release of calcein from the dye-entrapped LUVs was monitored
fluorometrically on a Shimadzu RF-5300 spectrofluorometer at an excitation
wavelength of 490 nm and at an emission wavelength of 520 nm at 30 °C.
Calcein-free LUVs were mixed with dye-loaded liposomes to adjust the lipid
concentration to the desired value. The maximum fluorescence intensity
corresponding to 100% leakage was determined by addition of 10% (w/v) Triton
X-100 (20 μL) to 2 mL of the sample. The percentage of apparent leakage was
calculated according to the relationship
% of apparent leakage ¼ 100 ðF  F0Þ=ðFt  F0Þ
where F and Ft are fluorescence intensities before and after addition of the
detergent, respectively, and F0 represents the fluorescence of intact vesicles.
2.5. Peptide binding
The binding of the peptides to LUVs composed of PG/PC (1/1) was
estimated on the basis of their Trp fluorescence [15]. Peptide solutions (4 μM)
were titrated with a vesicle suspension while the fluorescence spectra of the Trp
residue were recorded after every 45-min incubation for equilibration.
Fluorescence data were averaged for two independent samples after volume
correction for dilution (up to 5%).
2.6. Lipid flip-flop
The peptide-induced lipid flip-flop was detected using NBD-labeled LUVs
(PG/PC/C6-NBD-PC=50/49.5/0.5) and dithionite ion as previously reported
Fig. 2. CD spectra. The CD spectra of the peptides (25 μM) were measured at
30 °C in 1 mM PG/PC (1/1) SUVs.
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1 M Tris ([lipid]=40 mM, [dithionite]=60 mM) and incubated for 15 min at
30 °C to produce inner leaflet-labeled vesicles. The vesicles were immediately
separated from free dithionite by gel filtration (Bio-Gel A1.5 m, 1.5×30 cm
column). The fraction of NBD-lipids that had flopped during incubation in the
absence or presence of the peptide was measured on the basis of fluorescence
quenching by sodium dithionite. The asymmetrically NBD-labeled LUVs
(2.0 mL) were incubated with or without the peptide for various periods at 30 °C.
In the peptide-containing samples, 50 μL of a trypsin solution (9.6 mg/mL) was
added to 2-mL samples and reacted for 1 min to hydrolyze the peptide. After
addition of 20 μL of 1 M sodium dithionite/1 M Tris, NBD fluorescence was
monitored with excitation and emission wavelengths of 460 and 530 nm,
respectively. The percent flip-flop was calculated as described previously [12].
2.7. Peptide translocation
Translocation of the peptide into the inner leaflet of the bilayer was examined
with the use of MLVs composed of PG/PC/C6-NBD-PC (50/49.5/0.5) [19].
Small aliquots of the MLVs were added to a peptide solution or to a buffer as the
control in the presence of 10mM sodium dithionite. The fluorescence intensity of
NBD at 530 nm (excitation wavelength, 450 nm) was monitored at 30 °C. The
intensity was represented relative to the value in the absence of the dithionite ion.
2.8. Antimicrobial activity
The minimum inhibitory concentrations (MICs) of the peptides were
determined as described previously [20]. Briefly, E. coli (ATCC 25922) and S.
epidermidis (ATCC 12228) were cultured in 3% (w/v) Tryptic soy broth (TSB)
at 37 °C for 20 h. To obtain midlogarithmic phase microorganisms, 1-mL
aliquots of the cultures were transferred to 100 mL of fresh TSB broth and
incubated for 2–3 h. The cells were washed with 10 mM sodium phosphate/
100 mM NaCl, pH 7.4 buffer (NAPB) and resuspended in the same buffer. The
cell concentrations were estimated by measuring the absorbance at 600 nm
(ABS600). The relationship between the cell concentration and ABS600 was
predetermined as (CFU/mL=ABS600×3.4×10
8) for E. coli and (CFU/
mL=ABS600×1.6×10
8) for S. epidermidis. The suspensions were diluted to
4×105 CFU/mL. The inoculum (90 μL) was added to each well of 96-well
plates. The peptide samples (10 μL) were added to each well and the plates were
incubated at 37 °C for 3 h. TSB [6% (w/v), 100 μL] was added, and the plates
were incubated at 37 °C for 20 h. Cell growth was assessed by measuring the
ABS595 on a model 680 microplate reader (Bio-Rad, Hercules, CA). MIC was
defined as the lowest concentration of the peptide that inhibited growth.
2.9. Cytotoxicity
2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium,
monosodium salt (WST-1) was obtained from Roche Applied Science
(Mannheim, Germany). Alpha modification of Eagle's medium (AMEM) was
purchased from ICNBiomedicals (Aurora, OH). The cytotoxicity of the peptides
against Chinese Hamster Ovary (CHO)-K1 cells was assessed using the WST-1
assay [21] according to the manufacturer's procedure. The cells (1×104/well) in
AMEM containing 10% fetal bovine serum (FBS) were cultured in 96-well
microplates and incubated for 12 h under 5% CO2 at 37 °C. After removal of the
medium, the cells were incubated with 100 μL of the peptide dissolved in the
medium (100 μM) for 24 h at 37 °C. Ten microliters of the WST-1 solution was
added, and the cells were further incubated for 1 h. The percent cell viability was
determined by (ABS450−ABS655) for the peptide-treated cells/(ABS450−ABS655)
for the untreated cells×100. All measurements were made at least in triplicate.
2.10. Inner membrane permeability
o-Nitrophenyl-β-D-galactoside (ONPG) was purchased from Aldrich
(Milwaukee, WI). E. coli ML-35 (i−, y−, z+) strain was used to estimate the
inner membrane-permeabilizing activity of the peptides based on the method of
Lehrer [22]. The bacteria were resuspended in NAPB and adjusted to an ABS620
value of 0.35 (∼1×108 CFU/mL). The cells in 96-well plates were preincubated
with ONPG in NAPB containing 1% TSB (v/v) at 37 °C for 60 min. The peptidesolution in NAPB was then added to each well, and absorbance at 405 nm was
measured. The final concentrations of E. coli ML-35, ONPG, and the peptide
were 1×107 CFU/mL, 1.67 mM, and 2 μM, respectively. During the inner
membrane permeability assay, CFU of bacteria was also monitored. At various
time points, aliquots (10 μL) were taken from the sample solution and diluted
with the buffer solution (N100 fold) to stop the action of the peptides. Aliquots
(100 μL) of the diluted solution were seeded on Luria–Bertani agar plates and
CFU were counted after 12 h.
3. Results
3.1. CD spectra
The secondary structure of PEG-E19Q-MGa was compared
to that of Ac-E19Q-MGa and MG in the presence of 1 mM PG/
PC SUVs (Fig. 2). Because further addition of SUVs did not
change CD spectra (data not shown), the peptides were
completely bound to SUVs under these conditions. All peptides
conformed to helices as characterized by double minima at
208–209 and 222 nm and a maximum below 200 nm. The
[θ]222 values were −15000, −21700 and −26000 deg cm2
dmol−1 for PEG-E19Q-MGa, MG and Ac-F5W-E19Q-MGa,
respectively, indicating that in terms of helicity estimated
according to Chen et al. [23], the order was PEG-E19Q-MGa
(41.7%)bMG (63.9%)bAc-E19Q-MGa (78.0%).
3.2. Leakage activity
To investigate whether PEGylation alters the activity of the
parent peptide against liposomes or not, we compared the
membrane permeabilizing activities of the peptides. Fig. 3
shows the time course of leakage of the fluorescent dye from PG/
PC LUVs mimicking bacterial cell membranes. With respect to
leakage activity, the order was Ac-E19Q-MGa≈MGN PEG-
E19Q-MGa. An equivalent amount of PEG per se was
confirmed to have no effect on the membrane-permeabilizing
activities of MG or Ac-E19Q-MGa (data not shown).
3.3. Binding affinity
The binding affinity of the peptides for PG/PC membranes
was estimated on the basis of changes in tryptophan fluorescence
Fig. 3. Membrane-permeabilizing activity of the peptides at 30°C. The percent
leakage value of calcein is plotted as a function of time. PG/PC (1/1) LUVs.
[peptide]=0.8 μM. [lipid]=54.5 μM.
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intensity, λmax (A), and the intensity enhancement at 336 nm
(B) as a function of the lipid-to-peptide molar ratio (L/P). In
the absence of PG/PC liposomes, MG taking an unordered
structure [24] showed a peak at 352 nm, indicating the Trp
residue is exposed to the aqueous phase. PEG-E19Q-MGa
and Ac-E19Q-MGa showed spectra superimposable on that of
MG (spectra not shown), suggesting that there is no
interaction between the tryptophan residue of PEG-E19Q-Fig. 4. Changes in tryptophan fluorescence of the peptides upon binding to
PG/PC (1/1) LUVs at 30 °C. The wavelength of maximal intensity λmax (A) and
the fluorescence intensity at 336 nm (B) are plotted as a function of L/P
([peptide]=4.0 μM). The excitation wavelength was 280 nm. Peptides: squares,
MG; circles, PEG-E19Q-MGa; crosses, Ac-E19Q-MGa.MGa and the PEG moiety in contrast to the case of PEG-
tachyplesin [9]. The addition of LUVs caused a blue shift and a
simultaneous intensity enhancement, indicating that the fluor-
ophore is buried in a hydrophobic environment of the membrane
[15]. PEG-E19Q-MGa showed a smaller blue shift than the other
two peptides, indicating that the peptide penetrates less deeper
into the bilayer. MG and Ac-E19Q-MGa showed similar
changes in λmax. The binding of the latter two peptides was
obviously saturated at lower L/P values than that of PEG-E19Q-
MGa, indicating the lower binding affinity of PEG-E19Q-MGa.
However, all peptides were almost completely bound to PG/PC
membranes at L/P=68.1 in the leakage experiments. In
enhancement in fluorescence, the order was Ac-E19Q-
MGaNMGNPEG-E19Q-MGa. For MG, the intensity at L/P
values below 50 was larger than the saturated value, as reported
previously [15]. This abnormal behavior was suggested to be
due to the dimerization of MG [26].
3.4. Lipid flip-flop
We assessed the lipid flip-flop induced by the peptides using
a combination of NBD-PC and dithionite ions [12] (Fig. 5). Our
laboratory has reported that MG induces lipid flip-flop coupled
to pore formation [12]. PEG-E19Q-MGa (Fig. 5A) and Ac-
E19Q-MGa (Fig. 5B) also induced the transbilayer movementFig. 5. Coupling between dye leakage and lipid flip-flop. Time courses of
calcein leakage reproduced from Fig. 3 and lipid flip-flop are shown with
traces and symbols, respectively, for (A) PEG-E19Q-MGa, and (B) Ac-E19Q-
MGa. The lipid composition was PG/PC (1/1) for leakage experiments and
0.5 mol% C6-NBD-PC was included for lipid flip-flop measurements. [L]=
54.5 μM, [P]=0.8 μM.
Table 1
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noted that PEG-E19Q-MGa and Ac-E19Q-MGa induced flip-
flop of a similar extent, although the leakage activity of PEG-
E19Q-MGa was weaker.
3.5. Peptide translocation
With the conventional approach [25], the fluorescence
resonance energy transfer between tryptophan residues in
peptides and dansyl-labeled lipids incorporated into LUVs is
used to quantify the fraction of membrane-bound peptide.
However, the fluorescence energy transfer between the
tryptophan residue of PEG-E19Q-MGa and dansyl-labeled
lipids was not observed because of different fluorescence pro-
perties (Fig. 4). Therefore, the MLV method [19] was used
instead to estimate the translocation of the peptides across lipid
bilayers (Fig. 6). The addition of the reducing ion dithionite to
MLVs containing NBD-PC reduced the NBD moieties exposed
to the external aqueous phase, making them nonfluorescent.
The decrease in fluorescence, corresponding to the fraction of
the chromophores on the MLV surface, was about 23%,
indicating that the lamellarity of the vesicles is larger than 2. If
the peptides permeabilize only the outermost bilayers without
translocation, the reducing ion can react with the NBD moieties
facing the first interlamellar space, resulting in quenching of
less than 69 (23×3)%. The expected time course of quenching
in this case is shown as the calculated curve in Fig. 6. In
contrast, if the peptide translocates, it can permeabilize not only
the outermost bilayers but also the inner bilayers, resulting in
quenching of more than 69%. In this case, experimental
quenching curves should be below the calculated curve. The
quenching curves of PEG-E19Q-MGa, MG, and Ac-E19Q-
MGa were below the calculated curve at concentrations of 4.0,
1.0, and 2.0 μM, respectively, indicating all peptides
translocate across bilayers. It should be noted that this ex-
periment can only examine qualitatively whether a peptide can
translocate or not.Fig. 6. Detection of translocation of the peptides at 30 °C. Small aliquots of
MLVs composed of PG/PC/C6-NBD-PC (50/49.5/0.5) were injected into a
buffer or a peptide solution in the presence of 10 mM sodium dithionite. The
fluorescence (excitation at 450 nm, emission at 530 nm) was normalized to the
intensity in the absence of the quencher. The calculated trace is the curve in the
case of no translocation. [lipid]=100 μM.3.6. Biological activities
Table 1 summarizes the MIC values of the peptides against
Gram-negative E. coli and Gram-positive S. epidermidis. MG
and Ac-E19Q-MGa exhibited identical activities against both
types of bacteria. The PEGylated peptide showed 4-fold weaker
antimicrobial activity against both bacteria than the non-
PEGylated peptides, although the PEGylated peptide has the
same net charge as Ac-E19Q-MGa.
We then assessed the cytotoxicity of the peptides against
mammalian CHO-K1 cells (Table 2). At a concentration of
100 μM, the non-PEGylated peptides were highly toxic. The
cell viability was close to zero. In contrast, PEG-E19Q-MGa
was nontoxic.
3.7. Inner membrane permeability
To investigate why antimicrobial activity was decreased by
PEGylation, we compared the inner membrane-permeabilizing
activities of the peptides using E. coli ML-35 cells which lack
lactose permease necessary for the uptake of ONPG. If the
peptide induces the permeabilization of inner membranes,
ONPG enters the cytoplasm and is degraded by β-galactosidase,
producing o-nitrophenol that shows absorbance at 405 nm. The
PEGylated peptide neither induced the permeabilization of
inner membranes nor decreased the viability of bacteria during
60 min (Fig. 7). In contrast, MG induced a rapid increase in the
permeability of inner membranes, concomitant with a rapid
decrease in viability (Fig. 7), suggesting that the membrane-
permeabilizing activity mainly contributed to the bacterial
killing activity of MG.
4. Discussion
4.1. Effect of PEGylation on magainin 2-membrane
interactions
CD spectra (Fig. 2) showed that the PEGylation lowered the
helicity of magainin in the bilayer. The N-terminal hydrophilic
PEG moiety appears to prevent the N-terminus from beingTable 2






Fig. 7. Inner membrane permeabilization against E. coli ML-35 at 25 °C.
Absorbance at 405 nm of MG-(square), PEG-E19Q-MGa-(circle), and buffer-
(triangle) treated cells is shown as a function of time. [peptide]=20 μM. The
viability of bacteria (CFU/mL) is also shown with the corresponding closed
symbols.
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shallower insertion depth of the PEGylated peptide (Fig. 4).
Although PEGylation does not alter the secondary structure of
insulin [27], tachyplesin I [9], or interferon α-2b [28], these
proteins are stabilized by intramolecular disulfide bonds. In
contrast, Ac-E19Q-MGa exhibited the highest helicity, which is
ascribable to the stabilization of the helix in the N-terminal
region through elimination of the electrostatic repulsion
between the positively-charged N-terminus and the helix
macro dipole [29].
The binding affinity of the PEGylated peptide for PG/PC
membranes was weaker than those of the non-PEGylated
peptides (Fig. 4A). In addition to the lower helicity and the
shallower penetration, the charge-masking effect of the PEG
moiety [30] may also contribute to the lower binding affinity.
PEGylation also lowered the binding affinity of tachyplesin I
[9]. However, the decrease in affinity is more prominent for
MG than for tachyplesin I, because the depth of tachyplesin
in the membrane does not change upon PEGylation.
The binding affinity of Ac-E19Q-MGa with larger positive
charges was almost the same as that of MG (Fig. 4A) probably
because of two opposing factors, i.e., the enhanced electrostatic
interaction and the enhanced helicity of Ac-E19Q-MGa. The
former increases the binding affinity. We have reported that
F10W, E19Q-magainin 2-amide with +5 charges showed
enhanced affinity for PG/PC membranes compared to F10W-
magainin 2 with +3 charges [24]. On the other hand, the
increased helicity may lead to a decrease in binding affinity
because one peptide molecule induces a large positive curvature
strain to membranes, thereby destabilizing the peptide–lipid
system. No increase in helicity was observed for F10W, E19Q-
magainin 2-amide [24].
The λmax value of Ac-E19Q-MGa was almost the same as
that of MG, indicating similar locations in the membrane (Fig.
4A). However, the extent of enhancements in the presence of
membranes was quite different (Fig. 4B). The protonated
amino group is known to be an effective quencher for tryptophan
[31].The attachment of the large PEG moiety (5 kDa) to the
smaller parent peptide (2.5 kDa) weakened the intrinsic leakage
activity (Fig. 3), partly because the PEGylated peptide could
not efficiently induce a positive curvature strain required for
forming toroidal pores due to the lower helicity and the
shallower insertion. Another possibility is that the PEG
moiety, which is more extruded into the aqueous phase
compared to the case of the PEGylated tachyplesin I [9],
could clog the pore. Indeed, the leakage-to-flip-flop ratio of
PEG-E19Q-MGa was smaller than that of the acetylated
counterpart (Fig. 5). Ac-E19Q-MG, whose depth in the
membrane was almost the same as that of MG (Fig. 4A),
showed very similar membrane-permeabilizing activity to MG
against PG/PC LUVs (Fig. 3). We have reported that the
charge-enhanced peptide F10W, E19Q-magainin 2-amide had
less membrane-permeabilizing activity than F10W-magainin
2 due to the instability of the pore [24]. In the current case,
the pore destabilization caused by the increased charge
appears to be compensated for by increased pore-forming
activity due to the enhanced helicity (vide supra). Unlike with
magainin, PEGylation did not alter the depth of insertion and
therefore membrane-permeabilizing activity of tachyplesin I
[9].
The PEGylated peptide was translocated into the inner leaflet
of the bilayer (Fig. 6). The efficiency of NBD quenching
depends on several factors other than the translocating activity,
i.e., the binding affinity of each peptide for membranes and the
membrane permeabilization activity. The apparent reduced
translocation ability of the PEGylated peptide is at least partly
due to the smaller binding affinity (Fig. 4) and the weaker
membrane-permeabilizing activity against PG/PC (Fig. 3). The
L/P value for the outermost bilayers was smaller than 25, where
the PEGylated peptide did not bind completely to the membrane
(Fig. 4A).
4.2. Effect of PEGylation on biological activities
The non-PEGylated peptides were highly toxic to CHO-K1
cells at a concentration of 100 μM, whereas PEGylation
nullified the cytotoxicity (Table 2). The charge-masking effect
may contribute to the diminished toxicity. It is also possible that
the PEGylated peptide could not permeate the extracellular
matrix efficiently due to large steric hindrance of the PEG
moiety. PEGylation also lowered the cytotoxicity of tachyplesin
I [9].
Not only cytotoxicity but also antimicrobial activity was
reduced by PEGylation (Table 1). PEGylation has been re-
ported to decrease the antimicrobial activity of tachyplesin I
[9], nisin [8], and α-defensin [32]. However, the extent of
the reduction is strongly dependent on the peptide. In the
case of the magainin analogue, the decrease was only 4-fold.
The decrease is ascribable to the existence of outer mem-
branes and peptidoglycan layers, as discussed elsewhere [9].
The smaller binding affinity and the weaker membrane-
permeabilizing activity against PG/PC LUVs of the PEGy-
lated peptide (Fig. 4A) could also contribute to the weaker
antimicrobial activity. In contrast, the decrease in antimicrobial
2584 Y. Imura et al. / Biochimica et Biophysica Acta 1768 (2007) 2578–2585activity by PEGylation is more prominent for tachyplesin I
(32–64 fold). The mechanism of antimicrobial action of
tachyplesin I may involve binding to bacterial DNA [33],
although we have reported that membrane permeabilization
contributes mainly. The impairment of the membrane-
permeabilizing activity and DNA binding by PEGylation
could lead to the larger decrease in antimicrobial activity of
tachyplesin I.
5. Conclusion
We designed a PEGylated peptide based on the α-helical
antimicrobial peptide magainin 2 and examined the effects of
PEGylation on the mechanism of membrane permeabilization of
the peptide. The results were compared to those for the
PEGylated β-sheet tachyplesin I. The attachment of a large
PEG moiety (5 kDa) lowers the membrane binding for both
peptides. A reduction in membrane-permeabilizing activity
occurs only for magainin, because the PEGylation destabilizes
the secondary structure. However, the PEGylation does not
change the essential mode of action against lipid bilayers. The
PEGylation significantly reduces cytotoxicity and the antimi-
crobial activity at the same time. The extent of the decrease
depends on the peptide.
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